NGM Biopharmaceuticals, Inc. CEO William J. Rieflin Resigned

NGM Bio Appoints David J. Woodhouse, Ph.D. as Chief Executive Officer and Aetna Wun Trombley, Ph.D. as President and Chief Operating Officer

PRNewswire/ — NGM Biopharmaceuticals, Inc., a clinical stage biotechnology company focused on harnessing powerful biology underlying major diseases to…

Name: William J. Rieflin

Continent: North America

Country: USA

Company: NGM Biopharmaceuticals, Inc.

Position: CEO

Reason: Resigned

Replaced By: David J. Woodhouse

New Company: NGM Biopharmaceuticals, Inc.

New Position: Chairman

Announcement Date: September 30, 2018, 10:00pm

Resignation Date: September 30, 2018, 10:00pm

Source 1: https://www.prnewswire.com/news-releases/ngm-bio-appoints-david-j-woodhouse-phd-as-chief-executive-officer-and-aetna-wun-trombley-phd-as-president-and-chief-operating-officer-300721535.html